Skip to content
Search

Latest Stories

Submit Guest Post

Scientist sues King's College London over painful pipetting work at lab

Syed Mian did his pipetting job for lengthy hours ‘without rotation or a break throughout the day'.

Scientist sues King's College London over painful pipetting work at lab

A scientist has sued King's College London for £50,000 saying he developed repetitive strain injury after continually squeezing pipettes at the institute’s laboratory.

Dr Syed Mian, 36, an award-winning research fellow, said his intensive laboratory work at the college’s Denmark Hill Campus in south London work left him with severe pain in both hands and anxiety and the employer failed to ensure the place of work was safe for him.

The institute admitted a breach of duty but said Mian failed to alert it in time that he was suffering at work, a Mail Online report said.

According to his lawyers, 'pipetting' work required “a significant amount of pressure and he would do this task for lengthy periods without rotation or a break throughout the day”.

In July 2018, he experienced swelling along the side of the right wrist and the base of the thumb. Mian switched to his left hand for the work but developed a similar problem there too.

Currently working for the Francis Crick Institute, the stem cell expert said his pain and discomfort while at King’s College caused him depression and anxiety.

King’s college contended that the scientist, who should have reported his symptoms as a result of his work', continued his work despite suspecting it was the source of his problems.

The case will be heard at Central London County Court. But no date has been fixed for the trial.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less